Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional Results available

Study of Bendamustine Hydrochloride for the Treatment of Pediatric Patients With Relapsed or Refractory Acute Leukemia

ClinicalTrials.gov ID: NCT01088984

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT01088984. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:11 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Study of Bendamustine Hydrochloride for the Treatment of Pediatric Patients With Relapsed or Refractory Acute Leukemia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of phase 1 of this study is to establish the recommended phase II dose (RP2D). The primary objective of phase 2 of this study is to evaluate the safety and efficacy of bendamustine at the recommended pediatric dose for the treatment of pediatric patients with relapsed or refractory acute leukemia.

Study identification

NCT ID
NCT01088984
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Enrollment
43 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
1 Year to 20 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2010 (Type not available)
Primary completion
Aug 2011 (Actual)
Completion
Aug 2011 (Actual)
Last update posted
May 23, 2016

2010 – 2011

United States locations

U.S. sites
19
U.S. states
14
U.S. cities
19
Facility City State ZIP Site status
Teva Investigational Site 17 Orange California — —
Teva Investigational Site 12 San Diego California — —
Teva Investigational Site 10 St. Petersburg Florida — —
Teva Investigational Site 8 Baltimore Maryland — —
Teva Investigational Site 16 Boston Massachusetts — —
Teva Investigational Site 9 Detroit Michigan — —
Teva Investigational Site 1 Jackson Mississippi — —
Teva Investigational Site 5 Kansas City Missouri — —
Teva Investigational Site 14 St Louis Missouri — —
Teva Investigational Site 15 New York New York — —
Teva Investigational Site 18 Portland Oregon — —
Teva Investigational Site 11 Hershey Pennsylvania — —
Teva Investigational Site 7 Philadelphia Pennsylvania — —
Teva Investigational Site 19 Memphis Tennessee — —
Teva Investigational Site 3 Dallas Texas — —
Teva Investigational Site 4 Fort Worth Texas — —
Teva Investigational Site 13 Houston Texas — —
Teva Investigational Site 2 Seattle Washington — —
Teva Investigational Site 6 Milwaukee Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01088984, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 23, 2016 · Synced Nov 15, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.